Navigation Links
/C O R R E C T I O N -- Agendia B.V./
Date:6/26/2009

ssay is always clinically useful and indicates whether a patient is at low or high risk for metastasis and the resulting clarity is vital in helping physicians personalize treatment options.

"St. Gallen's guideline inclusion is a key step in further establishing MammaPrint as a standard of care. It also supports our commitment to upholding rigorous standards of quality and efficacy," said Dr. Bernhard Sixt, Agendia's President and Chief Executive Officer. "With MammaPrint we aim to provide breast cancer patients and their physicians with definitive answers to crucial treatment questions."

In addition to MammaPrint, the company also offers TargetPrint to further improve breast cancer treatment options. TargetPrint quantitatively determines the gene expression levels of HER2neu, estrogen and progesterone receptors. Ongoing research and development efforts continue to augment Agendia's ability to accurately predict breast cancer recurrence, and help physicians tailor individual treatment plans to their patients.

    For online access to the Annals of Oncology:
http://annonc.oxfordjournals.org/cgi/content/full/mdp322v1

About Agendia

Agendia is at the forefront of the personalized medicine revolution, striving to bring more effective, individualized treatment within reach of patients. Building on a cutting edge genomics platform for tumor gene expression profiling, the company's tests aim to help physicians more accurately tailor cancer therapy. The company markets four products, with several new genomic tests in development. Agendia collaborates with pharmaceutical companies in the development of highly effective personalized drugs in the area of oncology and was awarded the 2008 North American Oncology Clinical Diagnostics Healthcare Innovation Award by Frost & Sullivan. Agendia is based i
'/>"/>

SOURCE Agendia B.V.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Agendias Breast Cancer Recurrence Test MammaPrint Included in International St. Gallen Expert Consensus Recommendations
2. Agendias Breast Cancer Test MammaPrint(R) Identifies New Subset of Low Risk HER2+ Patients
3. Agendias MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
4. Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium
5. Agendias MammaPrint(R) Included in 2008 Dutch Institute for Healthcare Improvement CBO Guidelines
6. Agendia Launches TargetPrint(R) for Breast Cancer Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., NEW YORK, Nov. 6 Kery...old a conference call on Tuesday, November 10, 200...09 financial results and business outlook for the ...fficer of the Company, will host the call. Keryx ...d in a press release to be issued prior to the cal...
(Date:11/6/2009)..., ATLANTA, Nov. 6 GeoV..." or "the Company"), an Atlanta-based, biopharmace...ses caused by HIV-1 (Human Immunodeficiency Virus)...third quarter 2009 financial results and provided ..., President and Chief Executive Officer commented,...
(Date:11/6/2009)..., SAN DIEGO, Nov. 6 California Am..., 2009 as "No Drugs Down the Drain" week for its S... campaign sponsored by public and private agencies...aceutical pollution in our source water supplies. ... customers are encouraged to drop off expired or u...
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8California American Water Celebrates 'No Drugs Down the Drain' Week in San Diego 2Cardinal Health Foundation Awards 241 Million to Fund Patient Safety Initiatives 49339 1Cardinal Health Foundation Awards 241 Million to Fund Patient Safety Initiatives 49339 2Cardinal Health Foundation Awards 241 Million to Fund Patient Safety Initiatives 49339 3Cardinal Health Foundation Awards 241 Million to Fund Patient Safety Initiatives 49339 4Cardinal Health Foundation Awards 241 Million to Fund Patient Safety Initiatives 49339 5Cardinal Health Foundation Awards 241 Million to Fund Patient Safety Initiatives 49339 6Cardinal Health Foundation Awards 241 Million to Fund Patient Safety Initiatives 49339 7Hysterectomies Could Be Source of Stem Cells 49337 1Tianyin Pharmaceutical Co Inc Provides Fiscal 2010 Guidance 49332 1Tianyin Pharmaceutical Co Inc Provides Fiscal 2010 Guidance 49332 2Tianyin Pharmaceutical Co Inc Provides Fiscal 2010 Guidance 49332 3Tianyin Pharmaceutical Co Inc Provides Fiscal 2010 Guidance 49332 4Tianyin Pharmaceutical Co Inc Provides Fiscal 2010 Guidance 49332 5
(Date:11/6/2009)...thcare Trust of America, Inc. (the "REIT"), a self..., announced the execution of a Purchase and Sale A...fice building located in Englewood, Colorado for a...dical Center is located within the Englewood City ...t district. Hampden Place is located near the Swed...
(Date:11/6/2009)...ira, Inc. (NYSE: HSP ), a leading global specialt...today announced that the company will present at t...e on Wednesday, Dec. 2, 2009 in New York City. ,, .... Eastern time on Wednesday, Dec. 2, 2009. It wil... live audiocast accessible via the investor relati...
(Date:11/6/2009)...ne as years go by, researcher says , , FRI...sts that people with multiple sclerosis who have r...e are more likely to suffer from severe limitation.... , The findings, published Nov. 4 in Neurology ,...hin five years of developing it are nearly 50 perc...
(Date:11/6/2009)... additional large community H1N1 influenza clinics...epartment, the department announced today. They wi... Heights Saturday, Nov. 14 and 21, from 9 a.m. to ...an Parkway. At least 3,000 doses will be available... nasal spray and injectable versions of the vaccin...
(Date:11/6/2009)...y-published special supplement, the Journal of Car...s to prevent and treat venous thromboembolism (VTE...als throughout the world. Lippincott Williams &a...bring attention to VTE, a disease that includes bo...bosis and its most serious complication, pulmonary...
Breaking Medicine News(10 mins):Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 66,339 SF Medical Office Building Located in Englewood, Colorado 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 66,339 SF Medical Office Building Located in Englewood, Colorado 3Health News:Early Relapse of MS May Mean Fewer Issues Later 2Health News:Macomb County Announces Two Additional Communitywide H1N1 Flu Vaccine Clinics Saturday, Nov. 14 and 21; Clinic For Health Care Workers Only Set For Nov. 12 2Health News:Journal of Cardiovascular Nursing Urges Policies and Prevention To Reduce Deaths from Venous Thromboembolism 2Health News:Journal of Cardiovascular Nursing Urges Policies and Prevention To Reduce Deaths from Venous Thromboembolism 3
...s found that the availability of a portable eight-...ency room can significantly increase the number of...ing treatment. Results of the study, conducted at ...merica (RSNA). , "The hospital,s acquisition of ...
...veals that computed tomography (CT) colonography, ...al to screen for two diseases at oncecolorectal ca...ct adults over age 50. Results of the study will b...lorectal cancer, we were able to identify patients...
...008 As the connection between second-hand smoke a... legislation was passed to reduce such passive smo...ublished in the January 2009 issue of the America...ave recalibrated the CHD Policy Model to better pr...
...is a cold December day in,Memphis, Tennessee and F...amilo Villegas and LPGA star Morgan Pressel have g... that has brought three of the biggest names in,pr...m/cgi-bin/prnh/20081201/CLM117 ) , Singh, V...
...op dividing when their DNA is damaged, in a proces...amaged DNA from leading to unregulated cell divisi...lished in this week,s issue of PLoS Biology , has...t support the development of age-related diseases ...
... In the face of one of the most,severe economic do... Board of,Directors has approved an investment of ...ter Health Retirement Plan. Employee pension plans...ely,invested, the Sutter Health Retirement Plan ha...
Other Medicine News:Health News:Portable CT increases chance of stroke survival and recovery 2Health News:CT colonography offers 1-stop screening for cancer and osteoporosis 2Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 2Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 3Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 4Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 5Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 6Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 7Health News:Escape cancer, but age sooner? The dark side of the tumor suppressing process 2Health News:Sutter Health Invests Hundreds of Millions in Employee Pension 2
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: